← All research
ZAMBIA-HIV · Peer-reviewed
HIV, antiretroviral therapy, and cervical cancer burden in Zambia
Models how HIV prevalence and antiretroviral therapy coverage shape cervical cancer burden in Zambia, where women living with HIV face substantially elevated risk.
Key findings
- Almost 50% of cervical cancers in Zambia can be attributed to HIV coinfection.
- Antiretroviral therapy (ART) prevented approximately 5% of cancer cases.
- HIV-stratified prevention strategies will be essential for Zambia to achieve cervical cancer elimination targets.
Outputs
At a glance
- Themes
- Setting
- Zambia